Skip to main content

Advertisement

SpringerLink
Log in

Metastatic neurologic complications of non-Hodgkin’s lymphoma

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Neurologic complications of non-Hodgkin’s lymphoma represent challenging diagnostic and therapeutic issues. Leptomeningeal, epidural, and brain metastases are the most common neurologic complications, and each is associated with a poor prognosis. However, early recognition and intervention often result in improved quality of life and, for a subset of patients, an opportunity for longer survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Cancer facts and figures 1997. http://www.cancer.org

  2. Hennessy BT, Hanahan EO, Daly PA: Non-Hodgkin lymphoma: an update. Lancet Oncol 2004, 5:341–353.

    Article  PubMed  Google Scholar 

  3. Cancer facts and figures 2003. http://www.cancer.org

  4. MacKintosh FR, Colby TV, Podolsky WJ, et al.: Central nervous system involvement in non-Hodgkin’s lymphoma: an analysis of 105 cases. Cancer 1982, 49:586–595.

    Article  PubMed  CAS  Google Scholar 

  5. Hollender A, Kvaloy S, Lote K, et al.: Prognostic factors in 140 adult patients with non-Hodgkin’s lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis. Eur JCancer 2000, 36:1762–1768.

    Article  CAS  Google Scholar 

  6. Levitt LJ, Dawson DM, Rosenthal DS, et al.: CNS involvement in the non-Hodgkin’s lymphomas. Cancer 1980, 45:545–552.

    Article  PubMed  CAS  Google Scholar 

  7. Recht LD: Neurologic complications of systemic lymphoma. Neurol Clin 1991, 9:1001–1015.

    PubMed  CAS  Google Scholar 

  8. Chamberlain MC, Kormanik PA: Non-AIDS-related lymphomatous meningitis: combined modality therapy. Neurology 1997, 49:1728–1731.

    PubMed  CAS  Google Scholar 

  9. Bunn PA, Schein PS, Banks PM, et al.: Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited. Blood 1976, 47:3–10.

    PubMed  Google Scholar 

  10. Zinzani PL, Magagnoli M, Frezza G, et al.: Isolated central nervous system relapse in aggressive non-Hodgkin’s lymphoma: the Bologna experience. Leuk Lymphoma 1999, 32:571–576. luates frequency of CNS relapse in 175 patients with aggressive NHL who had attained CR with systemic chemotherapy but had not received prophylaxis.

    PubMed  CAS  Google Scholar 

  11. Griffin JW, Thompson RW, Mitchinson MJ, et al.: Lymphomatous leptomeningitis. Am J Med 1971, 51:200–208.

    Article  PubMed  CAS  Google Scholar 

  12. Tomita N, Kodama F, Kanamori H, et al.: Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-Hodgkin lymphoma. Cancer 2002, 95:576–580. ospective analysis regarding the incidence of CNS recurrence after CR and the influence of prophylactic intrathecal methotrexate and hydrocortisone.

    Article  PubMed  CAS  Google Scholar 

  13. Hollender A, Kvaloy S, Nome O, et al.: Central nervous system involvement following diagnosis of non-Hodgkin’s lymphoma: a risk model. Ann Oncol 2002, 13:1099–1107. rospective study of risk factors for CNS involvement in 2514 NHL patients without such involvement at diagnosis. The study proposes a risk model to guide clinicians in identifying high-risk patients and the use of CNS prophylaxis.

    Article  PubMed  CAS  Google Scholar 

  14. Grossman SA, Moynihan TJ: ‘Neoplastic meningitis’: neurologic complications of systemic cancer. Neurol Clin 1991, 9:843–856.

    PubMed  CAS  Google Scholar 

  15. Buckstein R, Lim W, Franssen E, et al.: CNS prophylaxis and treatment in non-Hodgkin’s lymphoma: variation in practice and lessons from the literature. Leuk Lymphoma 2003, 44:955–962.

    Article  PubMed  CAS  Google Scholar 

  16. Ersboll J, Schultz HB, Thomsen BLR, et al.: Meningeal involvement in non-Hodgkin’s lymphoma: symptoms, incidence, risk factors and treatment. Scand J Hematol 1985, 35:487–496.

    CAS  Google Scholar 

  17. van Besien K, Ha CS, Murphy S, et al.: Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood 1998, 91:1178–1184.

    PubMed  Google Scholar 

  18. Horak ID, Kremer AB, Magrath IT: Management of histologically aggressive lymphomas with a high risk of CNS disease. Baillieres Clin Hematol 1996, 9:707–726.

    Article  CAS  Google Scholar 

  19. Bos GM, van Putten WLJ, van der Holt B, et al.: For which patients with aggressive non-Hodgkin’s lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group. Ann Oncol 1998, 9:191–194. Analyzed risk of CNS relapse in 193 patients with NHL who had achieved CR with conclusion that no subgroup could be discriminated in which prophylactic treatment would be of substantial benefit.

    Article  PubMed  CAS  Google Scholar 

  20. Yoshida S, Morii K, Watanabe M, et al.: Characteristic features of malignant lymphoma with central nervous system involvement. Surg Neurol 2000, 53:163–167.

    Article  PubMed  CAS  Google Scholar 

  21. Recht L, Straus DJ, Cirrincione C, et al.: Central nervous system metastases from non-Hodgkin’s lymphoma: treatment and prophylaxis. Am J Med 1988, 84:425–435.

    Article  PubMed  CAS  Google Scholar 

  22. Haioun C, Besson C, Lepage E, et al.: Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin’s lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients. Ann Oncol 2000, 11:685–690.

    Article  PubMed  CAS  Google Scholar 

  23. Kesari S, Batchelor T: Leptomeningeal metastases. Neurol Clin 2003, 21:25–66.

    Article  PubMed  Google Scholar 

  24. Giglio P, Gilbert M: Neurological complications of non-Hodgkin’s lymphoma. In Lymphoma of the Nervous System. Edited by Batchelor T. St. Louis, MO: Elsevier; 2004:1363–1369.

    Google Scholar 

  25. Litam JP, Cabanillas F, Smith TL, et al.: Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis. Blood 1979, 54:1249–1257.

    PubMed  CAS  Google Scholar 

  26. Chamberlain MC: Leptomeningeal metastases: a review of evaluation and treatment. J Neurooncol 1998, 37:271–284.

    Article  PubMed  CAS  Google Scholar 

  27. DeAngelis LM: Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998, 38:245–252.

    Article  PubMed  CAS  Google Scholar 

  28. Grossman SA, Finkelstein DM, Ruckdeschel JC, et al.: Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 1993, 11:561–569.

    PubMed  CAS  Google Scholar 

  29. Desai J, Mitnick RJ, Henry DH, et al.: Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin lymphoma. Cancer 1999, 86:1840–1847.

    Article  PubMed  CAS  Google Scholar 

  30. Frick JC, Hansen RM, Anderson T, et al.: Successful high-dose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma. Arch Intern Med 1986, 146:791–792.

    Article  PubMed  CAS  Google Scholar 

  31. Glantz MJ, LaFollette S, Jaeckle KA, et al.: Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 1999, 17:3110–3116. Small randomized study comparing intrathecal liposomal cytarabine with intrathecal cytarabine for lymphomatous meningitis. The authors conclude that the efficacy of liposomal cytarabine is superior to standard cytarabine for the treatment of lymphomatous meningitis.

    PubMed  CAS  Google Scholar 

  32. Glantz MJ, Cole BF, Recht L, et al.: High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: Is intrathecal chemotherapy necessary? J Clin Oncol 1998, 16:1561–1567.

    PubMed  CAS  Google Scholar 

  33. Rubenstein JL, Combs D, Rosenberg J, et al.: Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 2003, 101:466–468.

    Article  PubMed  CAS  Google Scholar 

  34. Hanssens PEJ, Lagerwaard FJ, Levendag PC: Principles of radiotherapy of neoplastic meningiosis. J Neuro-oncol 1998, 38:145–150.

    Article  CAS  Google Scholar 

  35. Gray JR, Wallner KE: Reversal of cranial nerve dysfunction with radiation therapy in adults with lymphoma and leukemia. Int J Radiat Oncol Biol Phys 1990, 19:439–444.

    PubMed  CAS  Google Scholar 

  36. Chamberlain MC, Dirr L: Involved-field radiotherapy and intra-Ommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis. J Clin Oncol 1993, 11:1978–1984.

    PubMed  CAS  Google Scholar 

  37. Siegal T: Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy. J Neurooncol 1998, 38:151–157.

    Article  PubMed  CAS  Google Scholar 

  38. Burch PA, Grossman SA: Treatment of epidural cord compressions from Hodgkin’s disease with chemotherapy: a report of 2 cases and a review of the literature. Am J Med 1988, 84:555–558.

    Article  PubMed  CAS  Google Scholar 

  39. Van den Bent MJ: Neurological complications of systemic lymphoma. In Handbook of Clinical Neurology-Neuro-Oncology, part III. Edited by Vecht J. Elsevier Science; 1997: 25 (69):261–287.

  40. Wong ET, Portlock CS, O’Brien JP, et al.: Chemosensitive epidural spinal cord disease in non-Hodgkin’s lymphoma. Neurology 1996, 46:1543–1547.

    PubMed  CAS  Google Scholar 

  41. Epelbaum R, Haim N, Ben-Shahar M, et al.: Non-Hodgkin’s lymphoma presenting with spinal epidural involvement. Cancer 1986, 58:2120–2124.

    Article  PubMed  CAS  Google Scholar 

  42. Aabo K, Walbom-Jorgensen S: Central nervous system complications by malignant lymphomas: radiation schedule and treatment results. Int J Radiat Oncol Biol Phys 1986, 12:197–202.

    PubMed  CAS  Google Scholar 

  43. O’Neill BP: Neurologic complications of Hodgkin’s disease and the non-Hodgkin’s lymphomas. In Cancer Neurology in Clinical Practice. Edited by Schiff D, Wen PY. Totawa, NJ: Humana Press; 2002:371–384.

    Chapter  Google Scholar 

  44. Lyons MK, O’Neill BP, Marsh WR, et al.: Primary spinal epidural non-Hodgkin’s lymphoma: report of eight patients and review of the literature. Neurosurgery 1992, 30:675–680.

    Article  PubMed  CAS  Google Scholar 

  45. Batchelor T, Leahy N, Kaufman D: High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin’s lymphoma. Clin Lymphoma 2001, 2:116–119.

    Article  PubMed  CAS  Google Scholar 

  46. Tondini C, Ferreri AJ, Siracusano L, et al.: Diffuse large-cell lymphoma of the testis. J Clin Oncol 1999, 17:2854–2858.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Cox 315, 55 Fruit Street, 02114, Boston, MA, USA

    Jeanine Grier MD & Tracy Batchelor MD

Authors
  1. Jeanine Grier MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tracy Batchelor MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grier, J., Batchelor, T. Metastatic neurologic complications of non-Hodgkin’s lymphoma. Curr Oncol Rep 7, 55–60 (2005). https://doi.org/10.1007/s11912-005-0026-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-005-0026-9

Keywords

Search

Navigation